WOLFGANG WINKELMAYER to Biomarkers
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Biomarkers.
Connection Strength
0.253
-
Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records. Biometrics. 2015 Jun; 71(2):478-86.
Score: 0.064
-
A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11.
Score: 0.037
-
Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis. 2006 Jul; 48(1):159-66.
Score: 0.035
-
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2024 Sep; 106(3):369-391.
Score: 0.030
-
Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group. Kidney Int. 2023 06; 103(6):1028-1037.
Score: 0.028
-
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):281-295.
Score: 0.021
-
Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 10; 92(4):796-808.
Score: 0.019
-
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf. 2009 Oct; 18(10):932-40.
Score: 0.011
-
Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis. 2006 Mar; 47(3):509-17.
Score: 0.009